Subtype
Urinary Tract Carcinoma
CI-CAN-00007014Explore in graph →
326 active trials11 approved drugs23 evidence items
- NCIt
- C192669
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007014Explore in graph →
Clinical trials
852 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (127)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03988309 | STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA | completed | N/A | 554 | Pacific Edge LimitedINDUSTRY | 2 | May 31, 2025 | clinicaltrials |
| NCT02439060 | PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit) | completed | N/A | 156 | University of Southern CaliforniaOTHER | 1 | Apr 23, 2025 | clinicaltrials |
| NCT06818799 |
| Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer |
| completed |
| N/A |
| 50 |
| Helwan UniversityOTHER |
| 1 |
| Feb 12, 2025 |
| clinicaltrials |
| NCT06789224 | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device(REMOVE) | completed | N/A | 136 | Lindis Bloodcare GmbHINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT05522257 | PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas | completed | N/A | 25 | Leiden University Medical CenterOTHER | 1 | Dec 9, 2024 | clinicaltrials |
| NCT02408406 | PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers | completed | N/A | 140 | City of Hope Medical CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT02643043 | UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch | completed | N/A | 219 | Matthew Milowsky, MDOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT03584659 | Patient-reported Outcomes in Bladder Cancer(iBLAD) | completed | N/A | 230 | Rigshospitalet, DenmarkOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT04077359 | Prospective Trial for Examining Hematuria Using Computed Tomography(PROTEHCT) | completed | N/A | 300 | Oslo University HospitalOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT05070039 | Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population | completed | N/A | 40 | Sohag UniversityOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT03125226 | TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer | completed | N/A | 12 | University of WashingtonOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03064308 | The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery(POETold) | completed | N/A | 11 | University of NottinghamOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02585362 | Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program | completed | N/A | 52 | Kantonsspital Winterthur KSWOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT02986867 | SAbR Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma | completed | N/A | 27 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT03794102 | Water Versus Saline as Irrigation Fluid for Ureteroscopy | completed | N/A | 150 | Emory UniversityOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT01803295 | Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC(OPTIMA) | completed | N/A | 80 | UroGen Pharma Ltd.INDUSTRY | 4 | Jun 16, 2017 | clinicaltrials |
| NCT01526486 | Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer | completed | N/A | 29 | Emory UniversityOTHER | 1 | May 6, 2015 | clinicaltrials |
Data updated 22 days agoSource updated May 31, 2025source: clinicaltrials